How many drugs treat Amyotrophic lateral sclerosis?

Drug Landscape tracks 6 marketed treatments for Amyotrophic lateral sclerosis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/amyotrophic-lateral-sclerosis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Amyotrophic lateral sclerosis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Amyotrophic lateral sclerosis (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Amyotrophic lateral sclerosis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Qalsody	TOFERSEN	Biogen Ma	Antisense Oligonucleotide [EPC]	Superoxide dismutase 1 (SOD1) mRNA	2023-01-01
Relyvrio	TAURURSODIOL	Amylyx		Phospholipase A2	2022-01-01
Radicava	EDARAVONE	Kk Bcj-94	edaravone		2017-01-01
Rilutek	RILUZOLE	Covis	Benzothiazole [EPC]	Sodium-dependent noradrenaline transporter	1995-01-01
Buphenyl	Buphenyl	Amgen		Aldose reductase, Histone deacetylase 1, Histone deacetylase 2
Radicava	Radicava	Shanghai Auzone Biological Technology Co., Ltd.		Polyunsaturated fatty acid lipoxygenase ALOX15

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Amgen · 1 drug in Amyotrophic lateral sclerosis
Amylyx · 1 drug in Amyotrophic lateral sclerosis
Biogen Ma · 1 drug in Amyotrophic lateral sclerosis
Covis · 1 drug in Amyotrophic lateral sclerosis
Kk Bcj-94 · 1 drug in Amyotrophic lateral sclerosis
Shanghai Auzone Biological Technology Co., Ltd. · 1 drug in Amyotrophic lateral sclerosis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Amyotrophic lateral sclerosis:

Cite this brief

Drug Landscape (2026). Amyotrophic lateral sclerosis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/amyotrophic-lateral-sclerosis. Accessed 2026-06-10.

Amyotrophic lateral sclerosis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing